New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 30, 2013
08:12 EDTRNNRexahn initiated with a Buy at Maxim
Target $1.50.
News For RNN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 17, 2015
16:16 EDTRNNRexahn COO Rakesh Soni to resign, effective July 21
Subscribe for More Information
July 14, 2015
09:09 EDTRNNRexahn awarded patent in Japan
Rexahn Pharmaceuticals announced that it was issued patent number 5749273 from the Japanese Patent Office entitled "Polymeric Systems for the Delivery of Anticancer Drugs" for the company’s novel CPMA drug delivery platform. This new CPMA drug delivery platform technology, developed by Rexahn, enables more precise, targeted delivery of anti-cancer drugs directly into cancer cells.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use